PR NEWSWIRE

Previous Stories

Caruso raises $9.3m Series A, assets under admin surge to $80bn

Apr 16 2026 - PR NewsWire

AI-native fund administrator secures $80m valuation from Icehouse Ventures, GD1 and Balmain, with enterprise customer wins including ASX-listed Centuria. SYDNEY,…


Orthocell Secures Approval to sell Remplir™ to the U.S. Department of Defence Hospital Network

Apr 16 2026 - PR NewsWire

Orthocell receives approval for Remplir™ to be used across the United States Department of Defence (DoD) and Veterans Affairs (VA)…


Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform

Apr 15 2026 - PR NewsWire

SYDNEY, April 15, 2026 /PRNewswire/ — Kazia Therapeutics (NASDAQ: KZIA), a clinical-stage oncology company developing differentiated therapies for cancers with…


Sistine Chapel Masterpieces Come to Life in Groundbreaking Immersive Exhibition in Sydney

Apr 15 2026 - PR NewsWire

One of the world’s most extraordinary artistic achievements is set to be experienced in a completely new way, as Sistine…


Voltavate’s Manufacturing Breakthrough Gains ARENA Backing to Transform Battery Production at Scale

Apr 15 2026 - PR NewsWire

A new approach to battery manufacturing, enabling in-house separator production and reduced supply chain dependence MELBOURNE, Australia, April 15, 2026…


Samsung Announces 2026 Home Audio line-up with Timeless Music Studio Wi-Fi Speakers and Advanced Q-Series Soundbars

Apr 15 2026 - PR NewsWire

New Music Studio speakers merge powerful sound with refined aesthetics, while the latest Q-Series soundbars introduce expanded AI enhancements. SYDNEY,…


Nexon Asia Pacific joins the Microsoft Intelligent Security Association

Apr 15 2026 - PR NewsWire

SYDNEY, April 15, 2026 /PRNewswire/ – Nexon Asia Pacific (Nexon), today announced it has become a member of the Microsoft Intelligent…


Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma

Apr 15 2026 - PR NewsWire

MELBOURNE, Australia and INDIANAPOLIS, April 15, 2026 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the…


Telix Successfully Prices and Upsizes US$600 Million Convertible Bonds

Apr 15 2026 - PR NewsWire

MELBOURNE, Australia and Indianapolis, April 15, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) ("Telix") is pleased to announce…


Telix Refinances Convertible Bonds

Apr 14 2026 - PR NewsWire

MELBOURNE, Australia and INDIANAPOLIS, Ind., April 14, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) ("Telix") today launches…


Analyse The Market From A Different Angle